Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Nasdaq  >  Spectrum Pharmaceuticals, Inc.    SPPI

Delayed Quote. Delayed  - 09/23 10:00:00 pm
4.72 USD   -1.87%
09/24 INSIDE THE FDA : Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI) and it..
09/23 Investigation of Spectrum Pharmaceuticals, Inc. Announced by Law ..
09/22 BRONSTEIN, GEWI : November 21, 2016
 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
09/19/2016 09/20/2016 09/21/2016 09/22/2016 09/23/2016 Date
4.72(c) 4.62(c) 4.47(c) 4.81(c) 4.72(c) Last
785 247 740 963 1 797 670 1 353 567 650 644 Volume
-2.07% -2.12% -3.25% +7.61% -1.87% Change
More quotes
Financials ($)
Sales 2016 136 M
EBIT 2016 -70,1 M
Net income 2016 -79,8 M
Debt 2016 -
Yield 2016 -
Sales 2017 114 M
EBIT 2017 -66,7 M
Net income 2017 -75,5 M
Debt 2017 -
Yield 2017 -
P/E ratio 2016 -
P/E ratio 2017
Capi. / Sales2016 2,79x
Capi. / Sales2017 3,32x
Capitalization 379 M
More Financials
Company
Spectrum Pharmaceuticals, Inc. engages in the acquisition, development, and commercialization of pipeline of late-stage clinical and commercial products.It targets non-Hodgkin's lymphoma, advanced metastatic colorectal cancer, acute lymphoblastic leukemia, and multiple myeloma.It operates through... 
More about the company
Surperformance© ratings of Spectrum Pharmaceuticals,
Trading Rating : Investor Rating :
More Ratings
Latest news on SPECTRUM PHARMACEUTICALS,
09/24 INSIDE THE FDA : Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI) and its Bladder Ca..
09/23 Investigation of Spectrum Pharmaceuticals, Inc. Announced by Law Offices of H..
09/22 BRONSTEIN, GEWIRTZ & GROSSMAN, LLC N : November 21, 2016
09/21 SHAREHOLDER NOTICE : Faruqi & Faruqi, LLP Encourages Investors Who Suffered Loss..
09/21 GLANCY PRONGAY & MURRAY LLP : Commences Investigation on Behalf of Spectrum Phar..
09/21 Rosen Law Firm Files Securities Class Action Against Spectrum Pharmaceuticals..
09/21 HYNES KELLER & HERNANDEZ, LLC : Announces Investigation of Spectrum Pharmaceutic..
09/20 Levi & Korsinsky, LLP Announces the Commencement of an Investigation Involvin..
09/20 Goldberg Law PC Announces an Investigation of Spectrum Pharmaceuticals, Inc.
09/20 SPECTRUM PHARMACEUTICALS NOTIFICATIO : Faruqi & Faruqi, LLP Encourages Investors..
More news
Sector news : Biotechnology & Medical Research - NEC
09/23DJAMGEN : FDA Approves Amgen's Biosimilar Version of Humira -- 2nd Update
09/23DJAMGEN : FDA Approves Amgen's Biosimilar Version of Humira -- Update
09/23DJAMGEN : FDA Approves Amgen's Biosimilar Version of Humira
09/21DJGILEAD SCIENCES : Halts Test of Bowel Disease Treatment
09/20 Bayer raises sales targets for top-selling drugs after Monsanto deal
More sector news : Biotechnology & Medical Research - NEC
News from SeekingAlpha
09/19 Disappointment Is Coming For Spectrum Pharmaceuticals
09/14 Ad Comm thumbs down on Spectrum's apaziquone; shares off 4%
09/14 Ad Comm review today for Spectrum Pharma's apaziquone
08/16 Seattle Genetics Has Upcoming Catalysts After All
08/10 HEALTHCARE - TOP 5 GAINERS / LOSERS : 00 am
Advertisement
Chart SPECTRUM PHARMACEUTICALS,
Duration : Period :
Spectrum Pharmaceuticals,  Technical Analysis Chart | SPPI | US84763A1088 | 4-Traders
Full-screen chart
Technical analysis trends SPECTRUM PHARMACE...
Short TermMid-TermLong Term
TrendsBearishBearishNeutral
Technical analysis
Income Statement Evolution
More Financials
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 4
Average target price 9,00 $
Spread / Average Target 91%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
Rajesh C. Shrotriya Chairman & Chief Executive Officer
Joseph G. Turgeon President & Chief Operating Officer
Kurt A. Gustafson Chief Financial Officer & Executive Vice President
Stuart Mitchell Krassner Independent Non-Employee Director
Anthony E. Maida Independent Non-Executive Director
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
SPECTRUM PHARMACEUTICA..-21.72%379
INCYTE CORPORATION-17.95%16 728
CELLTRION, INC.--.--%11 664
LONZA GROUP AG13.18%10 059
QUINTILES TRANSNATIONA..15.66%9 453
SEATTLE GENETICS, INC.24.40%7 845
More Results